| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $111.80 | $24.71 | 352.50% | 210.94x | 53.21x | 14.18x | 17.12x | 1.53x | $106.92M | 0.91% | $705.78M | 6.70 | $11.98B | 1,527.57 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.27 | $8.40 | 188.81% | 115.57x | 56.44x | 6.83x | 13.83x | 0.99x | $39.15M | 1.24% | $220.58M | 1.69 | $3.13B | 68.96 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.58 | $17.80 | 330.22% | 71.57x | 65.51x | 7.07x | 9.13x | 1.83x | $182.84M | 3.08% | $654.15M | 8.43 | $5.81B | 48.42 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $249.99 | $81.49 | 206.79% | 40.98x | 36.85x | 6.95x | 24.70x | 1.45x | $793.95M | 2.38% | $1.35B | 10.14 | $34.73B | 29.45 | ||
| VCEL | VERICEL CORP | $39.60 | $8.22 | 381.95% | 82.50x | 70.75x | 6.60x | 5.48x | 2.02x | $61.66M | 3.05% | $370.04M | 7.25 | $1.99B | 45.29 | ||
| RPRX | ROYALTY PHARMA PLC | $59.05 | $37.01 | 59.56% | 31.41x | 11.03x | 10.36x | 3.47x | 0.64x | $2.92B | 11.12% | $9.79B | 21.99 | $42.10B | 35.80 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.94 | $69.78 | 54.69% | 30.32x | 11.95x | 7.61x | 85.35x | 0.62x | $806.22M | 6.37% | $143.54M | 1.22 | $14.23B | 19.81 | ||
| KRYS | KRYSTAL BIOTECH INC | $340.03 | $86.63 | 292.52% | 41.12x | 43.56x | 22.79x | 7.41x | 2.18x | $257.78M | 2.57% | $1.36B | 46.03 | $9.65B | 41.35 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.05 | $7.82 | 54.05% | 12.68x | 11.08x | 5.24x | 3.29x | 1.11x | $82.01M | 11.50% | $217.65M | 3.68 | $571.75M | 7.39 | ||
| TGTX | TG THERAPEUTICS INC | $54.00 | $23.04 | 134.36% | 17.53x | 54.34x | 9.57x | 13.68x | 1.95x | $17.39M | 0.23% | $604.08M | 4.26 | $8.53B | 61.30 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.41 | $19.36 | 243.07% | 174.76x | 22.81x | 3.77x | 2.03x | 1.15x | $738.18M | 5.75% | $6.32B | 32.68 | $16.17B | 41.92 | ||
| TECH | BIO-TECHNE CORP | $72.27 | $16.84 | 329.18% | 61.77x | 34.61x | 9.28x | 5.38x | 1.94x | $263.22M | 2.34% | $2.11B | 13.52 | $11.36B | 32.67 | ||
| ADMA | ADMA BIOLOGICS INC | $9.14 | $7.17 | 27.45% | 12.69x | 11.49x | 4.07x | 5.02x | 0.74x | $116.47M | 5.58% | $408.21M | 1.79 | $2.11B | 9.05 | ||
| EXEL | EXELIXIS INC | $56.21 | $30.79 | 82.53% | 17.09x | 17.02x | 5.79x | 7.55x | 1.13x | $1.17B | 8.32% | $1.84B | 7.35 | $13.81B | 12.70 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.14 | $6.11 | -81.34% | 8.14x | -3.85x | 1.41x | 1.50x | 0.06x | $19.58M | 29.65% | $44.20M | 0.76 | $17.66M | 2.31 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $245.87 | $182.94 | 34.40% | 16.11x | 9.62x | 3.38x | 3.32x | 0.68x | $1.62B | 10.42% | $4.80B | 75.98 | $18.74B | 11.59 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $280.65 | $88.32 | 217.76% | 27.87x | 29.71x | 19.38x | 5.78x | 2.11x | $130.62M | 2.32% | $967.52M | 48.22 | $5.72B | 20.50 | ||
| MDXG | MIMEDX GROUP INC | $4.64 | $1.46 | 216.73% | 116.00x | -33.07x | 1.93x | 3.13x | 1.10x | $44.50M | 6.49% | $216.00M | 1.46 | $557.70M | 24.45 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $519.51 | $156.40 | 232.16% | 29.98x | 27.02x | 10.47x | 6.50x | 2.13x | $3.80B | 2.88% | $20.25B | 79.81 | $127.51B | 23.17 | ||
| UTHR | UNITED THERAPEUTICS CORP | $502.70 | $196.89 | 155.31% | 16.62x | 18.77x | 6.79x | 3.37x | 2.87x | $1.09B | 5.10% | $6.40B | 150.24 | $19.76B | 11.79 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.54 | $30.93 | 34.31% | 13.23x | 9.97x | 2.51x | 2.42x | 0.79x | $354.90M | 14.75% | $999.24M | 17.25 | $2.02B | 7.23 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $793.74 | $438.42 | 81.05% | 18.93x | 14.23x | 5.25x | 2.58x | 1.01x | $3.76B | 4.61% | $31.71B | 308.48 | $81.97B | 14.26 | ||
| INCY | INCYTE CORP | $122.19 | $60.54 | 101.82% | 15.05x | 34.47x | 4.21x | 3.90x | 1.69x | $1.92B | 7.84% | $6.34B | 31.66 | $20.82B | 10.07 | ||
| VCYT | VERACYTE INC | $41.21 | $6.96 | 492.14% | 28.62x | 39.42x | 5.87x | 2.39x | 113.83x | $165.99M | 5.04% | $1.39B | 17.36 | $3.05B | 21.85 |